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Figure 1. Panels A+C abd B+D illustrate respective dose 
distribution for Plan1 and Plan2 for one patient case. 
 
 
Conclusions: A differential target and dose prescription 
strategy was technically feasible with LDR-BT seed planning 
and resulted in a significant dose reduction to both urethra 
and bladder neck, as compared to standard clinical dose 
planning.  
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Purpose/Objective: Focal brachytherapy (BT) is investigated 
as an alternative to whole gland BT for salvage treatment of 
recurrent prostate cancer to potentially improve functional 
outcome while maintaining cancer control. The aim of this 
study was to evaluate feasibility and toxicity of such 
treatment using high-dose-rate (HDR) brachytherapy. 
Materials and Methods: Seventeen patients were included in 
this prospective pilot study from May 2012 to July 2014. All 
the patients had received primary external beam 
radiotherapy with total dose of 70-78 Gy and experienced 
biochemical failure according to Phoenix criteria. Inclusion 
criteria were PSA <10 at inclusion, no detectable metastases 
on FACBC-PET-CT or pelvic MRI and a visible relapse tumour 
on FACBC-PET-CT or multiparametric MRI. All patients 
performed a bone marrow aspiration to assess the presence 
of micrometastatic disease in bone marrow. The salvage BT 
was delivered in 3 fractions with planning aim of 10 Gy to the 
tumour volume. For each fraction, separated by two weeks, 
the needles were applied using transrectal ultrasound (US) 
guidance. The gross tumour volume (GTV) was delineated in 
the US images based the on pre-treatment MR and FACBC-
PET-CT imaging. The urethra and the rectum wall were also 
delineated. Intra-operative treatment planning optimisation 
was performed for each fraction. Dose-volume-histogram 
parameters were found and 2Gy-eqivalent (EQD2) total dose 
were calculated using the LQ-model. The toxicity was scored 
using the EORTC/RTOG scale. 
Results: The median age of the patients was 69 years (range: 
60-75). Table 1 summarises the key dosimetry parameters 
achieved for this study. The GTV was in average 24% the 
whole prostate gland (range: 6-56). For all the patients the 
GTV D90 was above the total planning aim of 78 Gy (EQD2, 
α/β = 3). 
 
 
 
There were a significant correlation between the number of 
needles used and the volume of the GTV (R2 = 0.39, p<0.001). 
However, no correlation was found between the number of 
needles and the GTV D90, or between the volume of the GTV 
and the GTV D90. 
The median follow-up was 9 months (range: 3-21). Three 
patients (16%) experienced grade 2 genitourinary (GU) or 
gastrointestinal (GI) symptoms (GU urge, pollakisuria and 
urine leakage). Only one patient reported grade 3 
pollakisuria. In Figure 1 the GU and GI toxicity grades are 
plotted against the total EQD2 dose for rectum D2cm3 and 
urethra D0.1cm3.  
 
Conclusions: Our results suggest that focal HDR salvage 
brachytherapy is feasible with a GTV D90 above the planning 
aim for all the patients. The toxicity was acceptable; 
however, longer follow up is needed.  
  
 
Poster Discussion: Intrafraction and interfraction 
management  
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Purpose/Objective: Respiratory motion cause significant 
dose errors in IMPT for lung cancer patients due to induced 
variations in range and the interplay effect. The aim of this 
study was to investigate the relation between the respiratory 
amplitude and the dose errors due to the these effects.  
Materials and Methods: Intensity-modulated proton therapy 
(IMPT) plans with co-planar beam directions perpendicular to 
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the the dominant Cranio-Caudal(CC) direction of motion were 
optimized for 4 NSCLC lung cancer patients in Pinnacle v9.1. 
The plans were made on mid-position CT with iGTV density 
override, spot size σ =6 mm and spot spacing 1σ. The total 
prescribed dose was 66Gy in 24 fractions to be delivered to 
>95% of planning target volume (PTV). The fractionated 
proton treatment delivery was simulated by an in-house 
developed time dependent simulation algorithm which 
integrates 4D deformation vector field (DVF) and realistic 
respiratory trace determined from CBCT images. The DVF 
describes the anatomical changes of each point over the 
respiratory cycle as a cyclic function. Each cycle is 
synchronously modified with the phase, scale and offset 
information from the real respiratory trace. The impact of 
the interplay effect in our simulation was reproduced through 
Dose with Interplay to be compared with a simple shift 
invariant blurring of the dose the Blurred Dose. We used 
the following formulas for quantifying the impact of interplay 
and range (blurring) effects on dose errors:  
 
Results: Dose errors introduced by the interplay effect 
demonstrated different relationship with the respiration 
amplitude compared to the blurring effects. The errors due 
to interplay effects showed linear relationship with the 
amplitude in all patients. The blurring effect on the other 
side caused dose error with quadratic dependence on the 
amplitude (Figure 1). Our preliminary data also suggest that 
the dose errors due to interplay effects exhibit faster rise 
rate with the amplitude as the tumor size increases. 
 
Conclusions: The dosimetric consequences from the interplay 
and range effects in proton therapy are related to the 
amplitude. Large tumors with higher amplitude of motion 
seem to be more sensitive to dose errors.  
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Purpose/Objective: A high accuracy is crucial in stereotactic 
body radiotherapy (SBRT) treatments, but may be 
compromised by both translations and rotations of the target 
during treatment. While target translations have been 
investigated in detail, only few studies have addressed 
rotations. This study presents the first measurements of 
time-resolved intra-fraction internal target translations and 
rotations during liver SBRT using CBCT projections. 
Materials and Methods: Twenty-seven patients with three 
implanted gold markers received three to six-fraction SBRT 
on a conventional LINAC. One to three CBCT scans were 
acquired during each fraction (186 CBCTs in total). The three 
markers were retrospectively automatically segmented on 
the CBCT projections using in-house developed software. The 
3D trajectory of each marker was estimated using a 
probability based method.  
Intra-fraction translation and rotation of the marker 
constellation with respect to the mean position over the 
whole scan were calculated using Singular Value 
Decomposition (SVD) (Fig 1.). Motion range and Pearson’s 
correlation coefficients (R) per scan between the six degrees 
of freedom were investigated for patients with motion 
amplitude exceeding 1mm.  
Results: Figure 1 shows an example of the time-resolved 
translation and rotation of the marker constellation during a 
CBCT acquisition. Table 1 presents the 2-98 percentile range 
of translation along and rotation around the Right-Left (RL), 
Superior-Inferior (SI) and Anterio-Posterior (AP) axis. The 
motion was the largest in the SI direction (mean range of 
8.93 mm) while the rotation was of similar magnitude around 
all three axes. Rotations higher than 10 degrees were 
occasionally observed. 
The highest correlation was observed between AP and SI 
translations (Fig 1.) with mean R = -0.85 (SD = 0.22). The 
negative correlation means that cranial motion is associated 
with posterior motion. There was significant correlation 
(either positive or negative) between the SI translation and 
RL rotation in general, except for five patients with 
substantial cardiac induced motion for at least one marker 
(gray bars in figure c). Thus cranial motion is associated with 
rotation around the RL axis in either direction, but 
consistently the same direction for the same patient. 
 
 
 
Conclusions: Highly time resolved translations and rotations 
of targets in liver SBRT were determined for the first time on 
a conventional LINAC using CBCT projections. Considerable 
intra-fraction translations and rotations were observed. 
